Fundraising Fox
PathogenDx
Scottsdale, US · Founded 2015 · Delaware corporation · 3 known investors
Find your way into PathogenDx
Sign up to see every warm intro you have to PathogenDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PathogenDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
Founders & leadership
PathogenDx was founded in 2015 by Michael Hogan and Milan Patel.
MH
Michael HoganCSO
MP
Milan PatelCEO and Co-FounderMilan Patel has over twenty years of experience in corporate and entrepreneurial settings, ranging from small and mid-size businesses to Fortune 50 companies. He is CEO of PathogenDx, which provides molecular pathogen detection assays for rapid identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
EL
Eric LachanceCo-Founder and Board MemberHe has prior experience in defense, diagnostics, and power sectors, with expertise in supply chain management, emergency management, and operational planning.
Investors · 3
7thirtylisted by 7thirtyBoulder · $100K – $1M
How we know: 7thirty's portfolio page · the VCSheet dataset · Not right? Tell us
Altitude Investment Managementlisted by Altitude Investment Management
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$11.6M disclosed across 3 rounds · 2016–2019
▶$675KraisedApr 2016 · 4 investors · Biotechnology
▶$675KraisedApr 2016 · 4 investors · Biotechnology
Officers, directors & promoters on the filing
- Eric LachanceExecutive Officer, Director
- Michael HoganExecutive Officer, Director
- Milan PatelExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $675K
- Minimum investment
- $50K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
GendxGenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.
GenedxGeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.
CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
MedicinalgenomicsMedicinal Genomics provides microbial and plant testing solutions for the cannabis, nutraceutical, and food safety industries through validated qPCR assays and automated liquid handling platforms. Their offerings enable rapid pathogen detection and species identification with turnaround times measured in hours rather than days.
Companies working in the same space as PathogenDx.
In the news
Frequently asked questions
- What does PathogenDx do?
- PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
- Who founded PathogenDx?
- PathogenDx was founded by Michael Hogan, Milan Patel in 2015.
- Who are PathogenDx's investors?
- PathogenDx's investors include 7thirty, Altitude Investment Management, Salveo Capital.
- How much funding has PathogenDx raised?
- PathogenDx has disclosed $11.6M raised across 3 rounds.
- Where is PathogenDx headquartered?
- PathogenDx is headquartered in Scottsdale, US.